C07C 251/36
With the carbon atoms of the oxyimino groups bound to hydrogen atoms
Official title: with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
C07C251/36 (With the carbon atoms of the oxyimino groups bound to hydrogen atoms) appears on 328 US grants and 208 published applications in this corpus.
Search patents in C07C- Granted patents
- 328
- Published applications
- 208
- Assignees
- 149
- Inventors
- 807
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 10 | 0 |
| 1992 | 9 | 0 |
| 1993 | 10 | 0 |
| 1994 | 6 | 0 |
| 1995 | 11 | 0 |
| 1996 | 23 | 0 |
| 1997 | 33 | 0 |
| 1998 | 12 | 0 |
| 1999 | 13 | 0 |
| 2000 | 10 | 0 |
| 2001 | 12 | 3 |
| 2002 | 9 | 6 |
| 2003 | 6 | 8 |
| 2004 | 3 | 13 |
| 2005 | 8 | 4 |
| 2006 | 6 | 6 |
| 2007 | 3 | 5 |
| 2008 | 5 | 8 |
| 2009 | 3 | 6 |
| 2010 | 7 | 6 |
| 2011 | 3 | 5 |
| 2012 | 6 | 6 |
| 2013 | 3 | 17 |
| 2014 | 8 | 8 |
| 2015 | 17 | 12 |
| 2016 | 8 | 9 |
| 2017 | 7 | 11 |
| 2018 | 6 | 12 |
| 2019 | 8 | 9 |
| 2020 | 12 | 8 |
| 2021 | 6 | 7 |
| 2022 | 7 | 14 |
| 2023 | 12 | 7 |
| 2024 | 5 | 10 |
| 2025 | 8 | 2 |
| 2026 | 0 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Lipids and compositions for the delivery of therapeutics28 Oct 2025US 12,453,776 B2Arbutus Biopharma Corporation
- Method for controlling phakopsora pachyrhizi having resistance against QoI fungicide14 Oct 2025US 12,439,917 B2Sumitomo Chemical Company, Limited
- Biodegradable lipids for the delivery of active agents22 Jul 2025US 12,364,762 B2Alnylam Pharmaceuticals, Inc.
- Biodegradable lipids for the delivery of active agents8 Jul 2025US 12,350,338 B2Alnylam Pharmaceuticals, Inc.
- Biodegradable lipids for the delivery of active agents1 Jul 2025US 12,343,398 B2Alnylam Pharmaceuticals, Inc.
- Aldoxime antibiotics and related methods24 Sep 2026US 2026/0283985 A1
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- New process for the manufacture of mdm2-p53 antagonists23 Jul 2026US 2026/0209169 A1Boehringer Ingelheim International GmbH
- Urease inhibiting composition and use of same19 Mar 2026US 2026/0078068 A1Fertinagro Biotech, S.L.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Lipids and compositions for the delivery of therapeutics102US 8,999,351 B2Tekmira Pharmaceuticals Corporation · 2015
- Lipids and compositions for the delivery of therapeutics101US 9,186,325 B2Tekmira Pharmaceuticals Corporation · 2015
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996